AstraZeneca scores win in race to treat ovarian cancer

AstraZeneca has made further headway in the race with larger competitor GlaxoSmithKline’s to use a promising new class of drugs to treat ovarian cancer.


Source: Reuters Health

Be the first to comment

Leave a Reply

Your email address will not be published.


*